Follow
Thomas Kislinger
Title
Cited by
Cited by
Year
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the …
C Théry, KW Witwer, E Aikawa, MJ Alcaraz, JD Anderson, ...
Journal of extracellular vesicles 7 (1), 1535750, 2018
79442018
Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases
A Taguchi, DC Blood, G del Toro, A Canet, DC Lee, W Qu, N Tanji, Y Lu, ...
Nature 405 (6784), 354-360, 2000
16422000
N ε-(carboxymethyl) lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression
T Kislinger, C Fu, B Huber, W Qu, A Taguchi, S Du Yan, M Hofmann, ...
Journal of Biological Chemistry 274 (44), 31740-31749, 1999
10801999
Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions
JA Coppinger, G Cagney, S Toomey, T Kislinger, O Belton, ...
Blood 103 (6), 2096-2104, 2004
9882004
RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy
TM Wendt, N Tanji, J Guo, TR Kislinger, W Qu, Y Lu, LG Bucciarelli, ...
The American journal of pathology 162 (4), 1123-1137, 2003
7972003
Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses
G Basta, G Lazzerini, M Massaro, T Simoncini, P Tanganelli, C Fu, ...
Circulation 105 (7), 816-822, 2002
7352002
RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E–null mice
LG Bucciarelli, T Wendt, W Qu, Y Lu, E Lalla, LL Rong, MT Goova, ...
Circulation 106 (22), 2827-2835, 2002
7252002
Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease
N Tanji, GS Markowitz, C Fu, T Kislinger, A Taguchi, M Pischetsrieder, ...
Journal of the American Society of Nephrology 11 (9), 1656-1666, 2000
6012000
Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice
MT Goova, J Li, T Kislinger, W Qu, Y Lu, LG Bucciarelli, S Nowygrod, ...
The American journal of pathology 159 (2), 513-525, 2001
5822001
Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling
T Kislinger, B Cox, A Kannan, C Chung, P Hu, A Ignatchenko, MS Scott, ...
Cell 125 (1), 173-186, 2006
5412006
Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice
E Lalla, IB Lamster, M Feit, L Huang, A Spessot, W Qu, T Kislinger, Y Lu, ...
The Journal of clinical investigation 105 (8), 1117-1124, 2000
5242000
EVpedia: a community web portal for extracellular vesicles research
DK Kim, J Lee, SR Kim, DS Choi, YJ Yoon, JH Kim, G Go, D Nhung, ...
Bioinformatics 31 (6), 933-939, 2015
3652015
A novel community driven software for functional enrichment analysis of extracellular vesicles data
M Pathan, S Keerthikumar, D Chisanga, R Alessandro, CS Ang, ...
Journal of extracellular vesicles 6 (1), 1321455, 2017
3402017
Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E–null mice
SAM Kislinger T, Tanji N, Wendt T, Qu W, Lu Y, Ferran LJ Jr, Taguchi A ...
Arteriosclerosis, Thrombosis, and Vascular Biology, 2001
3332001
The emerging role of extracellular vesicles as biomarkers for urogenital cancers
M Nawaz, G Camussi, H Valadi, I Nazarenko, K Ekström, X Wang, ...
Nature Reviews Urology 11 (12), 688-701, 2014
3132014
Integrating gene and protein expression data: pattern analysis and profile mining
B Cox, T Kislinger, A Emili
Methods 35 (3), 303-314, 2005
2382005
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands
I Weinreb, S Piscuoglio, LG Martelotto, D Waggott, CKY Ng, ...
Nature genetics 46 (11), 1166-1169, 2014
2172014
Recent advances in mass spectrometry based clinical proteomics: applications to cancer research
A Macklin, S Khan, T Kislinger
Clinical proteomics 17, 1-25, 2020
2112020
Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state
M Shimoda, S Principe, HW Jackson, V Luga, H Fang, SD Molyneux, ...
Nature cell biology 16 (9), 889-901, 2014
2112014
PRISM, a generic large scale proteomic investigation strategy for mammals* S
T Kislinger, K Rahman, D Radulovic, B Cox, J Rossant, A Emili
Molecular & Cellular Proteomics 2 (2), 96-106, 2003
2092003
The system can't perform the operation now. Try again later.
Articles 1–20